Biofrontera, Inc. (BFRI)
1.56
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 15:34
Biofrontera 1 Year Total Returns (Daily) : 92.59% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | 92.59% |
| September 04, 2026 | 91.92% |
| September 03, 2026 | 73.56% |
| September 02, 2026 | 80.95% |
| September 01, 2026 | 73.23% |
| August 31, 2026 | 72.67% |
| August 28, 2026 | 86.73% |
| August 27, 2026 | 73.26% |
| August 26, 2026 | 70.00% |
| August 25, 2026 | 63.79% |
| August 24, 2026 | 51.50% |
| August 21, 2026 | 69.01% |
| August 20, 2026 | 68.16% |
| August 19, 2026 | 52.69% |
| August 18, 2026 | 54.84% |
| August 17, 2026 | 45.16% |
| August 14, 2026 | 34.58% |
| August 13, 2026 | 32.63% |
| August 12, 2026 | 34.41% |
| August 11, 2026 | 33.03% |
| August 10, 2026 | 27.84% |
| August 07, 2026 | 33.68% |
| August 06, 2026 | 22.55% |
| August 05, 2026 | 21.57% |
| August 04, 2026 | 21.39% |
| Date | Value |
|---|---|
| August 03, 2026 | 14.42% |
| July 31, 2026 | 8.33% |
| July 30, 2026 | 17.14% |
| July 29, 2026 | 11.43% |
| July 28, 2026 | 3.74% |
| July 27, 2026 | -0.94% |
| July 24, 2026 | -1.36% |
| July 23, 2026 | 0.93% |
| July 22, 2026 | 19.87% |
| July 21, 2026 | 24.27% |
| July 20, 2026 | 19.02% |
| July 17, 2026 | 28.08% |
| July 16, 2026 | 32.74% |
| July 15, 2026 | 32.91% |
| July 14, 2026 | 23.26% |
| July 13, 2026 | 29.07% |
| July 10, 2026 | 29.72% |
| July 09, 2026 | 35.73% |
| July 08, 2026 | 56.38% |
| July 07, 2026 | 66.93% |
| July 06, 2026 | 65.71% |
| July 02, 2026 | 46.36% |
| July 01, 2026 | 46.80% |
| June 30, 2026 | 32.89% |
| June 29, 2026 | 69.55% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ANI Pharmaceuticals, Inc. | -26.23% |
| Corcept Therapeutics, Inc. | 60.02% |
| Veru, Inc. | -23.44% |
| Johnson & Johnson | 54.48% |
| Eli Lilly & Co. | 53.12% |